Physicians in the United States, Canada, and Mexico
Physicians with current and valid licenses in the United States, Canada,
or Mexico who read any 3 of the selected continuing medical education (CME)
articles in this issue of Archives of Neurology,
complete the CME Evaluation Form, and fax it to the number or mail it to the
address at the bottom of the CME Evaluation Form are eligible for category
1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation
Council for Continuing Medical Education to sponsor continuing medical education
for physicians. The AMA designates this educational activity for up to 3 hours
of category 1 CME credit per Archives of Neurology
issue toward the AMA Physician's Recognition Award (PRA). Each physician should
claim only those hours of credit that were actually spent in this educational
activity.
Physicians in Other Countries
Physicians with current and valid licenses in the United States, Mexico,
or Canada are eligible for CME credit even if they live or practice in other
countries. Physicians licensed in other countries are also welcome to participate
in this CME activity. However, the PRA is only available to physicians licensed
in the United States, Canada, or Mexico.
Statement of Educational Purpose
The Archives of Neurology provides new evidence
for the practice of neurology, neurosurgery, and other specialties whose goal
is to improve the neurological health of all people. Original contributions,
neurological reviews, neurology and public health, and history of neurology
are among the categories of articles published, but all contributions receive
a sympathetic reading by the Chief Editor. The journal's editorial board sets
the initial framework for the types of articles published, which is then modified
by feedback from editors, external peer reviewers, authors, and readers. We
are keen to receive submissions from practicing neurologists to provide new
insight for colleagues.
We want our readers to assess each article critically; this CME activity
is active, not passive. Does the article contribute in some way to the practice
of neurology? How could you modify your practice style to incorporate what
you have learned? How can you acquire more information, challenge the authors'
conclusions, or verify what you have read? Which of the articles in each issue
is least helpful in your quest for the best and most applicable evidence?
Earning Credit
To earn 1 hour of category 1 CME credit, you should read any 3 of
the CME articles listed below and complete the CME Evaluation Form.
To earn 3 hours of credit, read all of the articles listed below
and complete the CME Evaluation Form. The CME Evaluation Form must be
submitted within 4 weeks of the issue date. A certificate awarding up to 3
hours of category 1 CME credit will be faxed or mailed to you; it is then
your responsibility to maintain a record of credit received. Questions about
CME credit processing should be directed to The Blackstone Group; tel: (312)
419-0400, ext 225; fax: (312) 269-1636.
CME Evaluation Form
One of our goals is to assess continually the needs of our readers so
we may enhance the educational effectiveness of the Archives
of Neurology. To achieve this goal, we need your help. You must complete
the CME Evaluation Form to receive credit.
CME Articles in This Issue of Archives of Neurology
The articles listed below may be read for CME credit.
Experimental Neurotherapeutics: Leaps and Bounds (SEE ARTICLE)
Educational Objective: To review advances in
neurologic therapeutics.
Prospects for Vascular Endothelial Growth Factor Neurotherapeutics
(SEE ARTICLE)
Educational Objective: To explore the possible
role of vascular endothelial growth factor in neurologic therapeutics.
Therapies for Movement Disorders (SEE ARTICLE)
Educational Objective: To understand advances
in therapy for movement disorders.
Treatment of Patients With Stroke (SEE ARTICLE)
Educational Objective: To review advances in
stroke therapeutics.
Viral Infections of the Nervous System, 2002: Update
on Diagnosis and Treatment (SEE ARTICLE)
Educational Objective: To learn about recent
developments in diagnosis and treatment of viral infections of the nervous
system.
Darts in the Dark Cure Animal, but Not Human, Brain
Tumors (SEE ARTICLE)
Educational Objective: To evaluate the benefits
and shortcomings of treatments for brain tumors.
Current Immunotherapy for Demyelinating Diseases (SEE ARTICLE)
Educational Objective: To assess immunotherapy
for demyelinating diseases.
Therapy for the Epilepsies (SEE ARTICLE)
Educational Objective: To appraise therapies
for epilepsy.
Therapies for Disorders of the Neuromuscular Junction (SEE ARTICLE)
Educational Objective: To understand current
concepts in therapy for neuromuscular transmission disorders.
Friedreich Ataxia: Effects of Genetic Understanding
on Clinical Evaluation and Therapy (SEE ARTICLE)
Educational Objective: To explore potential
therapies arising from genetic understanding of Friedreich ataxia.
Diabetic Demyelinating Polyneuropathy Responsive to
Intravenous Immunoglobulin Therapy (SEE ARTICLE)
Educational Objective: To examine intravenous
immunoglobulin therapy in diabetic demyelinating polyneuropathy.
Demyelinating Neuropathy in Diabetes Mellitus (SEE ARTICLE)
Educational Objective: To identify the development
of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
Efficacy of Intravenous Immunoglobulin in Patients
With IgG Monoclonal Gammopathy and Polyneuropathy (SEE ARTICLE)
Educational Objective: To investigate intravenous
immunoglobulin in IgG monoclonal gammopathy and polyneuropathy.
Methylprednisolone Acts on Peripheral Blood Mononuclear
Cells and Endothelium in Inhibiting Migration Phenomena in Patients With Multiple
Sclerosis (SEE ARTICLE)
Educational Objective: To explore the mechanism
of steroid therapy in multiple sclerosis.
Antiepileptic Drug–Induced Bone Loss in Young
Male Patients Who Have Seizures (SEE ARTICLE)
Educational Objective: To assess bone loss
with antiepileptic therapy by dual-energy x-ray absorptiometry.
Plasma Homocysteine Levels, Cerebrovascular Risk Factors,
and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer
Disease (SEE ARTICLE)
Educational Objective: To investigate stroke
risk factors in Alzheimer disease by leukoaraiosis on computed tomographic
scanning.
Lymphocyte Oxidative DNA Damage and Plasma Antioxidants
in Alzheimer Disease (SEE ARTICLE)
Educational Objective: To evaluate lymphocyte
oxidative DNA damage and plasma antioxidants in Alzheimer disease.
Budipine Provides Additional Benefit in Patients With
Parkinson Disease Receiving a Stable Optimum Dopaminergic Drug Regimen (SEE ARTICLE)
Educational Objective: To learn about the efficacy
of bupidine added to dopaminergic therapy in patients with Parkinson disease.
Refractory Nonmotor Symptoms in Male Patients With
Parkinson Disease Due to Testosterone Deficiency: A Common Unrecognized Comorbidity
(SEE ARTICLE)
Educational Objective: To study the effect
of testosterone on nonmotor features of Parkinson disease.
Risk Factors of Cognitive Impairment in HIV-1–Infected
Persons With Different Risk Behaviors (SEE ARTICLE)
Educational Objective: To identify risk factors
of human immunodeficiency virus 1–related cognitive impairment.
Contribution of the Interleukin 4 Gene to Susceptibility
to Subacute Sclerosing Panencephalitis (SEE ARTICLE)
Educational Objective: To recognize host genetic
factors in Japanese patients with subacute sclerosing panencephalitis.
Regional N-Acetylaspartate
Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging
in Patients With Alzheimer Disease (SEE ARTICLE)
Educational Objective: To identify regional
metabolic changes with fast proton spectroscopic imaging in patients with
Alzheimer disease.
Brain Magnetic Resonance Imaging in Multiple-System
Atrophy and Parkinson Disease: A Diagnostic Algorithm (SEE ARTICLE)
Educational Objective: To evaluate magnetic
resonance imaging in the differential diagnosis in multiple system atrophy
with predominant parkinsonism and Parkinson disease.
Crossed Cerebellar Atrophy in Patients With Precocious
Destructive Brain Insults (SEE ARTICLE)
Educational Objective: To study crossed cerebellar
atrophy in epilepsy secondary to early-life traumatic brain injury.
Familial Aggregation of Parkinson Disease: A Comparative
Study of Early-Onset and Late-Onset Disease (SEE ARTICLE)
Educational Objective: To investigate familial
aggregation in early-onset and late-onset Parkinson disease.
Transient Visuospatial Disorder From Angiographic
Contrast (SEE ARTICLE)
Educational Objective: To learn about transient
visuospatial disorder following angiographic contrast.
Autopsy-Proven, Sporadic Pick Disease With Onset at
Age 25 Years (SEE ARTICLE)
Educational Objective: To understand that Pick
disease may present in young adults with behavioral problems.
Cytochrome c Oxidase
Deficiency Due to a Novel SCO2 Mutation
Mimics Werdnig-Hoffmann Disease (SEE ARTICLE)
Educational Objective: To read about a novel SCO2 mutation with spinal cord involvement mimicking spinal
muscular atrophy.
After you have read any 3 (to earn 1 hour of
category 1 CME credit) or all (to earn 3 hours of
credit) of these articles, please complete the CME Evaluation Form.
